Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma

Liu,Xiaomei; Wang,Aiyuan; Gao,Hong; Yuan,Zhengwei; Jiao,Yisheng

doi:10.3892/ijo.2012.1540

Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma

Authors:
- Xiaomei Liu
- Aiyuan Wang
- Hong Gao
- Zhengwei Yuan
- Yisheng Jiao
View Affiliations

Affiliations: Experiment Research Center, Shengjing Hospital of China Medical University, Shenyang, P.R. China, Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, P.R. China, Experiment Research Center, Shengjing Hospital of China Medical University, Shenyang, P.R. China, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, P.R. China
Published online on: July 3, 2012 https://doi.org/10.3892/ijo.2012.1540
Pages: 1021-1028

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer has the highest mortality rate of all gynecological malignancies. Livin, a novel member of the inhibitor of apoptosis protein family, has been found to be expressed in various malignancies and is suggested to have poor prognostic significance. However, no data are available concerning the significance of livin in ovarian cancer. In the present study, we detected the expression of livin isoforms in human epithelial ovarian cancer (EOC) tissues using semi-quantitative RT-PCR and western blot assays. The data indicated that livin expression positive ratio was much higher in cancer tissues compared to those in benign ovarian tumors and normal ovarian specimens. To determine the role of livin in the process of ovarian cancer growth, RNA interference mediated by recombinant lentivirus vectors expressing livin shRNA was applied to induce a long-lasting downregulation of livin gene expression in SKOV3 human ovarian cancer cell line. Cell apoptosis and chemosensitivity were evaluated by MTT assay and flow cytometry, respectively, following downregulation of livin expression, and the cleavage of molecular markers of the mitochondrial apoptotic signaling pathway was investigated by immunoblotting. Livin knockdown with siRNA enhanced spontaneous and drug-induced apoptosis in SKOV3 cells. The inhibition of livin resulted in profound pro-apoptotic and antiproliferative effects, and was associated with the activation of caspase signaling. In conclusion, these data suggested that livin plays an important role in inhibiting the apoptosis of ovarian cancer cells. Specific silencing of livin expression could promote cell apoptosis, enhance chemotherapy sensitivity and may be a promising target for further research in clinical chemotherapy of epitheliod ovarian cancer.

View Figures

View References

1.	Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar
2.	Campos SM and Ghosh S: A current review of targeted therapeutics for ovarian cancer. J Oncol. 1493622010.PubMed/NCBI
3.	Siwak DR, Carey M, Hennessy BT, et al: Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. J Oncol. 5689382010.PubMed/NCBI
4.	Feeley KM and Wells M: Precursor lesions of ovarian epithelial malignancy. Histopathology. 38:87–95. 2001. View Article : Google Scholar : PubMed/NCBI
5.	Kim A, Ueda Y, Naka T and Enomoto T: Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res. 31:142012. View Article : Google Scholar : PubMed/NCBI
6.	Trimble EL, Wright J and Christian MC: Treatment of platinum-resistant ovarian cancer. Expert Opin Pharmacother. 2:1299–1306. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Agarwal R and Kaye SB: Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 3:502–516. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Roy N, Mahadevan MS, McLean M, et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:167–178. 1995. View Article : Google Scholar : PubMed/NCBI
9.	Rothe M, Pan MG, Henzel WJ, Ayres TM and Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1243–1252. 1995. View Article : Google Scholar : PubMed/NCBI
10.	Liston P, Roy N, Tamai K, et al: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 379:349–353. 1996. View Article : Google Scholar : PubMed/NCBI
11.	Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
12.	Chen Z, Naito M, Hori S, Mashima T, Yamori T and Tsuruo T: A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun. 264:847–854. 1999. View Article : Google Scholar : PubMed/NCBI
13.	Richter BW, Mir SS, Eiben LJ, et al: Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol. 21:4292–4301. 2001. View Article : Google Scholar : PubMed/NCBI
14.	Salvesen GS and Duckett CS: IAP proteins: blocking the road to death’s door. Nat Rev Mol Cell Biol. 3:401–410. 2002.
15.	Kempkensteffen C, Hinz S, Christoph F, et al: Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumour Biol. 28:132–138. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Ashhab Y, Alian A, Polliack A, Panet A and Ben Yehuda D: Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 495:56–60. 2001. View Article : Google Scholar : PubMed/NCBI
17.	Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS and Dixit VM: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 10:1359–1366. 2000. View Article : Google Scholar : PubMed/NCBI
18.	Nedelcu T, Kubista B, Koller A, et al: Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res Clin Oncol. 134:237–244. 2008. View Article : Google Scholar : PubMed/NCBI
19.	Kim DK, Alvarado CS, Abramowsky CR, et al: Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Pediatr Dev Pathol. 8:621–629. 2005. View Article : Google Scholar : PubMed/NCBI
20.	Ye L, Song X, Li S, et al: Livin-α promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Prostate. 71:42–51. 2011.
21.	Dasgupta A, Alvarado CS, Xu Z and Findley HW: Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma. Biochem Biophys Res Commun. 400:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
22.	Wang TS, Ding QQ, Guo RH, et al: Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Biomed Pharmacother. 64:333–338. 2010. View Article : Google Scholar : PubMed/NCBI
23.	Mousavi-Shafaei P, Ziaee AA, Azizi E and Zangemeister-Wittke U: Antisense-mediated melanoma inhibitor of apoptosis protein downregulation sensitizes G361 melanoma cells to cisplatin. Anticancer Drugs. 17:1031–1039. 2006. View Article : Google Scholar
24.	Jiao YS, Wang YL, Zhang SL, Liu XM and Hao FJ: The expression and significance of Livin and Smac in epithelial ovarian carcinoma tissues. Modern Oncol. 17:296–299. 2009.
25.	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26.	Igney FH and Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2:277–288. 2002. View Article : Google Scholar : PubMed/NCBI
27.	Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S and Watanabe N: Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer. 46:299–304. 2004. View Article : Google Scholar : PubMed/NCBI
28.	Ka H and Hunt JS: Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol. 163:413–422. 2003. View Article : Google Scholar : PubMed/NCBI
29.	Yagihashi A, Asanuma K, Tsuji N, et al: Detection of anti-livin antibody in gastrointestinal cancer patients. Clin Chem. 49:1206–1208. 2003. View Article : Google Scholar : PubMed/NCBI
30.	Chang H and Schimmer AD: Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007. View Article : Google Scholar : PubMed/NCBI
31.	Ma L, Huang Y, Song Z, et al: Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ. 13:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
32.	Wagener N, Crnkovic-Mertens I, Vetter C, et al: Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney. Br J Cancer. 97:1271–1276. 2007. View Article : Google Scholar : PubMed/NCBI
33.	Alvarez-Salas LM and DiPaolo JA: Molecular approaches to cervical cancer therapy. Curr Drug Discov Technol. 4:208–219. 2007. View Article : Google Scholar : PubMed/NCBI
34.	Crnkovic-Mertens I, Wagener N, Semzow J, et al: Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis. Cell Mol Life Sci. 64:1137–1144. 2007. View Article : Google Scholar : PubMed/NCBI
35.	Pirollo KF and Chang EH: Targeted delivery of small interfering RNA: approaching effective cancer therapies. Cancer Res. 68:1247–1250. 2008. View Article : Google Scholar : PubMed/NCBI
36.	Kleinberg L, Florenes VA, Silins I, et al: Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Cancer. 109:228–238. 2007. View Article : Google Scholar : PubMed/NCBI
37.	Gong J, Chen N, Zhou Q, Yang B, Wang Y and Wang X: Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas. J Clin Pathol. 58:1081–1085. 2005. View Article : Google Scholar : PubMed/NCBI
38.	Crnkovic-Mertens I, Hoppe-Seyler F and Butz K: Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene. 22:8330–8336. 2003. View Article : Google Scholar : PubMed/NCBI
39.	Crnkovic-Mertens I, Muley T, Meister M, et al: The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells. Lung Cancer. 54:135–142. 2006. View Article : Google Scholar : PubMed/NCBI
40.	Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S and Wood MJ: Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 29:341–345. 2011. View Article : Google Scholar : PubMed/NCBI
41.	Feril LB Jr: Ultrasound-mediated gene transfection. Methods Mol Biol. 542:179–194. 2009. View Article : Google Scholar : PubMed/NCBI